Apoptotic sphingolipid ceramide in cancer therapy.
Apoptotic sphingolipid ceramide in cancer therapy.
复制标题
DOI:
10.1155/2011/565316
复制
发表时间:
2011
影响因子:
5.3
通讯作者:
Lin CF
中科院分区:
文献类型:
--
作者:
Huang WC;Chen CL;Lin YS;Lin CF
Apoptosis, also called programmed cell death, is physiologically and pathologically involved in cellular homeostasis. Escape of apoptotic signaling is a critical strategy commonly used for cancer tumorigenesis. Ceramide, a derivative of sphingolipid breakdown products, acts as second messenger for multiple extracellular stimuli including growth factors, chemical agents, and environmental stresses, such as hypoxia, and heat stress as well as irradiation. Also, ceramide acts as tumor-suppressor lipid because a variety of stress stimuli cause apoptosis by increasing intracellular ceramide to initiate apoptotic signaling. Defects on ceramide generation and sphingolipid metabolism are developed for cancer cell survival and cancer therapy resistance. Alternatively, targeting ceramide metabolism to correct these defects might provide opportunities to overcome cancer therapy resistance.
登录
查看更多内容
影响因子:
50.3
作者:
Carracedo, A;Lorente, M;Velasco, G
通讯作者:
Velasco, G
影响因子:
4.2
作者:
Dahmer, MK
通讯作者:
Dahmer, MK
影响因子:
4.7
作者:
Dumitru, Claudia A.;Sandalcioglu, Ibrahim E.;Gulbins, Erich
通讯作者:
Gulbins, Erich
DOI:
10.1016/j.bbrc.2006.02.070
发表时间:
2006-04-21
影响因子:
3.1
作者:
Akao, Y;Banno, Y;Nozawa, Y
通讯作者:
Nozawa, Y
影响因子:
11.4
作者:
Bonhoure, E.;Lauret, A.;Cuvillier, O.
通讯作者:
Cuvillier, O.